Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-blind, Randomized, Clinical Trial Comparing the Efficacy of 6 Cycles Versus 12 Cycles Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma

NCT03633552 is registered in ClinicalTrials.gov with Mashhad University of Medical Sciences as lead sponsor.

NCT NCT03633552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03633552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-blind, Randomized, Clinical Trial Comparing the Efficacy of 6 Cycles Versus 12 Cycles Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma
Lead sponsor
Mashhad University of Medical Sciences
Phase
Phase 3
Overall status
Unknown status
Start date
March 3, 2018
Completion date
April 3, 2021
Enrollment
62 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma of brain, glioblastoma multiforme of brain